MDR1 expression predicts outcome of Ph+ chronic phase CML patients on second-line nilotinib therapy after imatinib failure

✍ Scribed by Agrawal, M; Hanfstein, B; Erben, P; Wolf, D; Ernst, T; Fabarius, A; Saussele, S; Purkayastha, D; Woodman, R C; Hofmann, W-K; Hehlmann, R; Hochhaus, A; Müller, M C

• Book ID: 125474888
• Publisher: Nature Publishing Group
• Year: 2014
• Tongue: English
• Weight: 831 KB
• Volume: 28
• Category: Article
• ISSN: 0887-6924
• DOI: 10.1038/leu.2014.6